dihexa renal toxicity study 1mL(10 mM in DMSO) - Neurotrophic Peptide Enhancer For patients with myotonic dystrophy
For patients with myotonic dystrophy type 1 a rare, dominantly inherited, progressive disorder that affects multiple organ systems and results in decreased life expectancy there are currently no approved therapies. Stem cell, Granulocyte Colony Stimulating Factor and or Dihexa to promote limb function recovery in a rat sciatic nerve damage repair model: Experimental animal studies PMC Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration European Journal of Clinical Pharmacology Springer Nature Link Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide Scientific Reports Pathway based network medicine identifies novel natural products for Alzheimer's disease Alzheimer's Research & Therapy Springer Nature Link Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect
Pay in 4 interest-free payments of $5.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




